France Artificial Organs and Bionics Market Size (2024 - 2029)

The French artificial organs and bionics market is projected to experience significant growth over the forecast period, driven by factors such as the increasing incidence of road accidents and advancements in technology. The market's expansion is further supported by the rising demand for organ transplants, which artificial organs and bionics can effectively address due to the scarcity of donor organs. Despite the challenges posed by the high cost of procedures, the development and approval of innovative products, like artificial hearts, are expected to contribute positively to the market's size.

Market Size of France Artificial Organs and Bionics Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.20 %
Market Concentration Medium

Major Players

France Artificial Organs and Bionics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

France Artificial Organs & Bionics Market Analysis

The French artificial organs and bionics market is expected to witness a CAGR of around 5.2% during the forecast period.

The COVID-19 outbreak significantly upended solid organ transplant (SOT) practice across the country. While attempting to sustain life-saving transplant programs, such as heart, lung, and liver transplantations, transplant associations first advised delaying non-urgent renal transplantations. Thus, the pandemic caused a global decline in transplant activity that was unprecedented and rapid. Furthermore, it was difficult to determine the appropriate course of action for afflicted patients. As per the NIH's data published in January 2021, the mortality rate for the recipients of solid organ transplants in France was around 35% during the COVID-19 pandemic. However, post-covid, transplantation activities resumed as before. As a result, the market is expected to grow significantly over the forecast period.

The major factors that are responsible for the growth of the artificial organs and bionics market are the rising incidence of road accidents and technological advancements in the artificial organ and bionics market. For instance, according to the data from European Commission, in 2021, road fatalities in France increased by 16% compared to 2020. The demand for organ donors is ever-increasing and is extremely high compared to the actual supply. Bionics and artificial organs can cater to the needs of those who require organ transplantations and replacements. They can replicate the function of damaged organs. Another primary factor is the scarcity of donor organs. The lack of availability of potential organs to transplant has been a major issue.

Furthermore, artificial organs are being increasingly used in France, and companies are focusing more on developing them. For instance, in January 2021, Carmat, a French company, developed an artificial heart and received a CE mark for its device for sale in European countries. Approval of artificial heart systems increased the shares of Carmat to the highest in the last seven years. Carmat raised EUR 40.5 million (USD 42.77 million) in funding in April 2022. The funding was raised to finance the production of its Aeson artificial heart, which the company believes will provide an alternative treatment option for people with heart failure. With such new products entering France, the market studied is anticipated to witness strong growth over the forecast period.

However, the high cost of procedures is expected to impede the market's growth.

France Artificial Organs & Bionics Industry Segmentation

As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. Artificial Organs are made by a human and are implemented in human bodies with living tissue. Bionics refers to the replacement or improvement of body parts by mechanical kinds. 

The French artificial organs and bionics market is segmented by type (artificial organ (artificial heart, artificial kidney, cochlear implants, other organ types) and bionics (vision bionics, ear bionics, orthopedic bionics, cardiac bionics)). The report offers the value (in USD million) for the above segments.

By Type
Artificial Organ
Artificial Heart
Artificial Kidney
Cochlear Implants
Other Organ Types
Bionics
Vision Bionics
Ear Bionics
Orthopedic Bionics
Cardiac Bionics
Need A Different Region Or Segment?
Customize Now

France Artificial Organs and Bionics Market Size Summary

The French artificial organs and bionics market is poised for significant growth, driven by technological advancements and an increasing demand for organ replacements. The market is recovering from the disruptions caused by the COVID-19 pandemic, which had a profound impact on solid organ transplant practices. The scarcity of donor organs and the rising incidence of road accidents have heightened the need for artificial organs and bionics, which can effectively replicate the functions of damaged organs. Companies like Carmat are at the forefront, developing innovative solutions such as artificial hearts, which have received regulatory approvals and garnered substantial funding. These developments are expected to propel the market forward, despite challenges like the high cost of procedures.

The market's expansion is further supported by the growing prevalence of chronic diseases and organ failures, alongside government and organizational initiatives. Technologies such as 3-D printing and tissue engineering are advancing rapidly, enhancing the capabilities of artificial organs. The presence of numerous companies in France, including SPARTHA Medical and PIXIUM VISION, is fostering innovation in the sector. These firms are leveraging advancements in various scientific fields to develop cutting-edge bionic systems. The involvement of key global players with robust research funding and distribution networks is also contributing to the market's growth trajectory. As a result, the artificial organs and bionics market in France is expected to experience robust growth in the coming years.

Explore More

France Artificial Organs and Bionics Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Incidence of Road Accidents

      2. 1.2.2 Scarcity of Donor Organs

      3. 1.2.3 Technological Advancements in Artificial Organs and Bionics

    3. 1.3 Market Restraints

      1. 1.3.1 Expensive Procedures

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD Million)

    1. 2.1 By Type

      1. 2.1.1 Artificial Organ

        1. 2.1.1.1 Artificial Heart

        2. 2.1.1.2 Artificial Kidney

        3. 2.1.1.3 Cochlear Implants

        4. 2.1.1.4 Other Organ Types

      2. 2.1.2 Bionics

        1. 2.1.2.1 Vision Bionics

        2. 2.1.2.2 Ear Bionics

        3. 2.1.2.3 Orthopedic Bionics

        4. 2.1.2.4 Cardiac Bionics

France Artificial Organs and Bionics Market Size FAQs

The France Artificial Organs and Bionics Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)

Boston Scientific Corporation, Ossur, Medtronic PLC, Getinge AB and Abiomed Inc are the major companies operating in the France Artificial Organs and Bionics Market.

France Artificial Organs and Bionics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)